• Aucun résultat trouvé

Efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF.

N/A
N/A
Protected

Academic year: 2021

Partager "Efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF."

Copied!
31
0
0

Texte intégral

Loading

Figure

Table 1: Characteristics of the 67 patients at the start of the third anti-TNF
Table 2:  Factors associated with clinical response at weeks 6 and 20 (univariate analysis)
Table 3: Adverse events occurring under the third anti-TNF

Références

Documents relatifs

The Ge-on-Si material was band-engineered by tensile strain and n-type doping to compensate the energy difference between direct and indirect band gaps for efficient light

This paper reports the clinical and anatomical results, including mid-term (1-year) follow-up, of WEB aneurysm treatment in the accumulated population of the WEBCAST, French

» Le prince alla dans le coffre du roi mais ne trouva rien à part une flaque bleue. Soudain, le liquide se cristallisa et devint une magnifique épée ornée d’une

numériquement, un fichier contenant un spectre discret (les contributions des isotopes pairs du krypton étant absentes) est utilisé pour ajuster cette courbe

Conclusions: Based on data from the INSTAGE and INPULSIS trials, nintedanib had a similar effect on FVC decline over 24 weeks, and a similar safety and tolerability profile, in

Lean Aircraft Initiative Plenary Workshop Communications IPT October 16, 1996 Presented by: Deneen Silviano... L EAN

Il est nécessaire, une fois de plus, de bien distinguer la lactation de l’allaitement ; quasiment toutes les femmes peuvent avoir une lactation (sauf pour les

The ‘Comparison between experiments and numerical simulations’ section presents a numerical study and its comparison with experimental results on the following aspects: particle